TLR3 and cancer: TLR3 stimulation promoted metabolic reprograming in cancer cells, switching oxidative phosphorylation to anabolic glycolysis (through upregulation of HIF-1α) and enabling better adaptation to hypoxia and oxidative stress in the TME [28].